-

Seek Labs Invited to Present at BIO CEO & Investor Conference

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel gene therapies, announced its upcoming participation at the BIO CEO & Investor Conference, which will take place in New York City from February 26-27, 2024. Seek Labs was selected to speak about the Company’s most recent developments as part of the conference’s scheduled programming. The BIO CEO & Investor Conference gathers global industry-leading executives and investors from across the life sciences industry.

Presenting their most recent technology developments, Seek Labs CEO, Jared Bauer, will be on stage presenting to industry leaders. This appearance follows Seek Labs’ recent announcement in November on the release of SeekIt™, a complete point-of-care diagnostic testing platform in a portable, single-use device. SeekIt brings laboratory-quality testing technology out of a clinic or laboratory setting and into the hands of patients.

“I am excited to represent Seek Labs and our innovations at the BIO CEO & Investor Conference,” said Jared Bauer, CEO. “We are thankful for the exciting opportunity to showcase our innovation in diagnostic and pharmaceutical technologies. I am immensely proud of our company and our dedicated team who continue to drive our success.”

“We are thrilled to see Seek Labs—a BioUtah member— featured in the programming at the BIO CEO & Investor Conference,” said Kelvyn Cullimore, President & CEO of BioUtah. “Seek Labs has made significant advances in diagnostic and pharmaceutical innovations that demonstrate the cutting-edge healthcare solutions coming out of Utah’s biotechnology and life sciences sector.”

About Seek Labs

Seek Labs is a company united by a vision to advance scientific discovery and universal solutions. Seek Labs strives to innovate healthcare solutions that bridge gaps between patients, providers, and treatments. Seek Labs is united by the passion of our founders and their shared beliefs that healthcare solutions should empower individuals and serve their specific needs. Today—after years of experimentation, failure, and breakthrough— Seek Labs is developing new solutions for point-of-care diagnostics and pharmaceutical technologies that have the potential to revolutionize the detection and treatment of diseases.

Seek Labs is headquartered in Salt Lake City, Utah. Seek Labs is a proud member of the BioHive, a collective representing the life science and healthcare innovation ecosystem in Utah. BioHive is dedicated to all the ways our work can positively impact the lives of our community, our teams, and patients.

Contacts

Bridget Baldwin
Director of Communications, Seek Labs
bridget@seeklabs.com

Seek Labs


Release Versions

Contacts

Bridget Baldwin
Director of Communications, Seek Labs
bridget@seeklabs.com

Social Media Profiles
More News From Seek Labs

Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a biotechnology company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the publication of a peer-reviewed paper in Viruses (MDPI), revealing the first successful use of a CRISPR-based therapeutic to treat African Swine Fever Virus (ASFV) in pigs. The findings demonstrate the company’s proprietary CRISPR-based therapeutic successfully reduced viremia, enabling rec...

Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery programmable therapeutics, and point-of-care diagnostics, today announced an expansion of its Global Disease Atlas™ to include multiple hemorrhagic fever viruses. BioSeeker™, the company’s AI-powered discovery engine, has completed comprehensive genomic mapping across a suite of high-priority hemorrhagic fever viruses (HFV), which include Ebola virus, Marburg virus, Lassa...

Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced progress toward developing the world’s first pan-orthopoxvirus therapeutic, a breakthrough with significant implications for global health security. Orthopoxviruses are part of a group of double-stranded DNA viruses in the Poxviridae family that infect mammals, which include subtypes like human smal...
Back to Newsroom